121 related articles for article (PubMed ID: 1494801)
1. Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer.
Querzoli P; Ferretti S; Marzola A; Tassinari D; Indelli M; Marchetti E; Fabris G; Nenci I
Tumori; 1992 Oct; 78(5):287-90. PubMed ID: 1494801
[TBL] [Abstract][Full Text] [Related]
2. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.
DeSombre ER; Thorpe SM; Rose C; Blough RR; Andersen KW; Rasmussen BB; King WJ
Cancer Res; 1986 Aug; 46(8 Suppl):4256s-4264s. PubMed ID: 2425944
[TBL] [Abstract][Full Text] [Related]
3. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J
Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays.
Andersen J; Thorpe SM; King WJ; Rose C; Christensen I; Rasmussen BB; Poulsen HS
Eur J Cancer; 1990 Apr; 26(4):442-9. PubMed ID: 1694085
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.
Allred DC; Bustamante MA; Daniel CO; Gaskill HV; Cruz AB
Arch Surg; 1990 Jan; 125(1):107-13. PubMed ID: 1688490
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222.
Miller RT; Hapke MR; Greene GL
Cancer; 1993 Jun; 71(11):3541-6. PubMed ID: 8490902
[TBL] [Abstract][Full Text] [Related]
8. [Immunocytochemical assay of estrogen receptors in puncture products of breast carcinomas].
Faverly D; Querton G; Degeyter M; Lenglet G; Devleeschouwer N; Leclercq G
Bull Cancer; 1990; 77(7):667-74. PubMed ID: 2207355
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.
von Kleist S; Berling J; Koltzenburg J; Gropp H
J Cancer Res Clin Oncol; 1988; 114(6):623-7. PubMed ID: 2462564
[TBL] [Abstract][Full Text] [Related]
13. Correlation between ERICA and DCC assay in hormone receptor assessment of human breast cancer.
De Lena M; Marzullo F; Simone G; Labriola A; Tommasi S; Petroni S; Paradiso A
Oncology; 1988; 45(4):308-12. PubMed ID: 2455257
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis.
Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Thorpe SM
Int J Gynecol Pathol; 1993 Jul; 12(3):246-52. PubMed ID: 7688353
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
[TBL] [Abstract][Full Text] [Related]
16. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
[TBL] [Abstract][Full Text] [Related]
17. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of ER-ICA and enzyme immunoassay for the quantitation of estrogen receptors in breast cancer.
Hanna W; Mobbs BG
Am J Clin Pathol; 1989 Feb; 91(2):182-6. PubMed ID: 2464923
[TBL] [Abstract][Full Text] [Related]
19. [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].
Ozaki T
Gan To Kagaku Ryoho; 1992 Mar; 19(3):361-6. PubMed ID: 1371912
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Robertson JF; Bates K; Pearson D; Blamey RW; Nicholson RI
Br J Cancer; 1992 May; 65(5):727-30. PubMed ID: 1534019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]